Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according ...

Many neurological diseases damage specific parts of the brain, even though the harmful protein involved is present throughout the brain.

A new study combines tau PET with network mapping to prove remote circuit disruption drives cognitive symptoms in PSP.

Patients may not know that these treatments are experimental or about the risks they may pose. The latest in AJC's ...

Medical conditions - full list. Notifiable conditions are medical issues that could potentially compromise your ability to drive safely. These include sleep apnoea, fainting (sync ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced ...

Scientists studying brain aging have turned to an unexpected research partner living right in our homes. What they discovered about the aging feline brain may reshape how we understand and treat ...

Credit: Getty Images Researchers discuss the potential neurologic effects of the menopausal transition on cognitive decline and multiple sclerosis progression. Menopause is increasingly recognized as ...

New treatments for dry macular degeneration are helping slow vision loss, and researchers are testing therapies that may restore sight. Here’s what to know. Dry age-related macular degeneration is the ...

While there is currently no cure for geographic atrophy, certain treatments, such as complement inhibitors, can help slow its progression by targeting immune system activity that damages the macula.

Geographic atrophy (GA) is a condition that typically progresses slowly, with lesions expanding by about 1 square millimeter per year, leading to blind spots due to retinal deterioration. Treatment ...